These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26888789)
1. Vinay Prasad on the use of exaggerated language in cancer research, and how it can mislead doctors, patients, and the public. Prasad VK Oncology (Williston Park); 2016 Feb; 30(2):120-1. PubMed ID: 26888789 [No Abstract] [Full Text] [Related]
2. The Use of Superlatives in Cancer Research. Abola MV; Prasad V JAMA Oncol; 2016 Jan; 2(1):139-41. PubMed ID: 26512913 [No Abstract] [Full Text] [Related]
3. Patient attitudes, behaviours, and other factors considered by doctors when estimating cancer patients' anxiety and desire for information. Fröjd C; Lampic C; Larsson G; Birgegård G; von Essen L Scand J Caring Sci; 2007 Dec; 21(4):523-9. PubMed ID: 18036016 [TBL] [Abstract][Full Text] [Related]
4. What does the fact of advertising convey to patients? Adamjee A; Alfi D; Agarwal D; Braithwaite Y; Chan J; Chey M; Cho H; Choi C J Am Coll Dent; 2005; 72(3):22-3. PubMed ID: 16623135 [No Abstract] [Full Text] [Related]
5. Of hospital advertising truths, half truths, and the academic medical center. Andreopoulos S Pharos Alpha Omega Alpha Honor Med Soc; 2007; 70(1):47-50. PubMed ID: 17357754 [No Abstract] [Full Text] [Related]
6. The marketing of physicians' services: should doctors advertise? Leventhal RC Health Mark Q; 1995; 12(4):49-61. PubMed ID: 10143889 [No Abstract] [Full Text] [Related]
7. Of truths, half truths, and less than half truths on the road to health. Johns MM Pharos Alpha Omega Alpha Honor Med Soc; 2007; 70(1):50-1. PubMed ID: 17357755 [No Abstract] [Full Text] [Related]
8. Medical doctors and consumers view medical advertising. Burton GE Health Mark Q; 1991; 9(1-2):81-95. PubMed ID: 10116307 [TBL] [Abstract][Full Text] [Related]
10. Marketing: effective use of advertisements on your website. Moore R Int J Pharm Compd; 2014; 18(3):210-1. PubMed ID: 25306768 [No Abstract] [Full Text] [Related]
11. "Right to Try" Laws: The Gap between Experts and Advocates. Dresser R Hastings Cent Rep; 2015; 45(3):9-10. PubMed ID: 25944200 [No Abstract] [Full Text] [Related]
12. Dilemmas in the compassionate supply of investigational cancer drugs. Lewis JR; Lipworth W; Kerridge I; Doran E Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421 [TBL] [Abstract][Full Text] [Related]
13. Superlatives are commonly used in news coverage of cancer drugs, study finds. McCarthy M BMJ; 2015 Nov; 351():h5803. PubMed ID: 26525225 [No Abstract] [Full Text] [Related]
14. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077 [TBL] [Abstract][Full Text] [Related]
16. Progress in cancer care: the hope, the hype, and the gap between reality and perception. Saltz LB J Clin Oncol; 2008 Nov; 26(31):5020-1. PubMed ID: 18794538 [No Abstract] [Full Text] [Related]
17. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer. Morgensztern D; Pennell NA; Subramanian J; Govindan R Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555 [TBL] [Abstract][Full Text] [Related]